HBIO President David Green to Present At 2009 UBS Global Life Sciences Conference On September 23, 2009

• Press Release
• Source: Harvard Bioscience, Inc.
• On 11:30 am EDT, Thursday September 10, 2009

HOLLISTON, Mass., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO - News), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:30 p.m. local time at the Grand Hyatt Hotel in New York.

Related Quotes

Symbol	Price	Change
HBIO	3.60	-0.08

{"s" : "hbio","k" : "c10,l10,p20,t10","o" : "","j" : ""}

To hear a live webcast of our presentation, visit the "Presentations & Webcasts" tab on our Company website at www.harvardbioscience.com. Mr. Green's presentation will be available at www.ibb.ubs.com or our website by clicking on the investor presentation icon. Our presentation will be available by replay shortly after the actual presentation time and will be available and archived for thirty days. The presentation will cover the historical and expected future performance of the business. There will be a question and answer session following the presentation. Some of the information, particularly regarding Denville Scientific, Inc, to be presented by Mr. Green or provided in response to questions, may contain information that has not previously been disclosed. Additionally, any material financial or other statistical information presented in our presentation or in the question and answer session, which has not been previously disclosed, will be archived and available in the Investor Relations section of our website.

About Harvard Bioscience

Harvard Bioscience ("HBIO") is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments and apparatus, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. HBIO sells its products to thousands of researchers in over 100 countries primarily through its 900 page catalog (and various other specialty catalogs), its website and through its distributors, including GE Healthcare, Thermo Fisher Scientific and VWR. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain with additional facilities in France and Canada. For more information, please visit www.harvardbioscience.com.

The Harvard Bioscience, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6426

For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com.

Harvard Bioscience, Inc.
David Green, President
  dgreen@harvardbioscience.com
Chane Graziano, CEO
  cgraziano@harvardbioscience.com
Tom McNaughton, CFO
  tmcnaughton@harvardbioscience.com
508 893 8999
Fax: 508 429 8478